WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast to gene fusions involving protein kinases, such as the BCR-ABL fusion in chronic myeloid leukemia [21], therapeutic targets for cancers harboring gene fusion involving transcription factors are more elusive owed to their complex functions, as shown in this study.